Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for CNS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 33.29%
March 31, 2026 28.11%
December 31, 2025 19.46%
September 30, 2025 29.38%
June 30, 2025 30.62%
March 31, 2025 31.93%
December 31, 2024 30.70%
September 30, 2024 41.77%
June 30, 2024 24.74%
March 31, 2024 28.56%
December 31, 2023 36.48%
September 30, 2023 20.44%
June 30, 2023 27.12%
March 31, 2023 29.33%
December 31, 2022 30.16%
September 30, 2022 28.44%
June 30, 2022 17.42%
March 31, 2022 28.85%
December 31, 2021 43.35%
September 30, 2021 32.84%
June 30, 2021 35.69%
March 31, 2021 41.08%
December 31, 2020 0.80%
September 30, 2020 30.64%
June 30, 2020 35.78%
Date Value
March 31, 2020 7.71%
December 31, 2019 32.46%
September 30, 2019 34.23%
June 30, 2019 30.71%
March 31, 2019 42.77%
December 31, 2018 27.24%
September 30, 2018 30.32%
June 30, 2018 27.18%
March 31, 2018 30.57%
December 31, 2017 20.53%
September 30, 2017 26.53%
June 30, 2017 24.78%
March 31, 2017 25.48%
December 31, 2016 29.23%
September 30, 2016 25.10%
June 30, 2016 28.47%
March 31, 2016 22.49%
December 31, 2015 8.44%
September 30, 2015 21.80%
June 30, 2015 24.72%
March 31, 2015 24.89%
December 31, 2014 19.12%
September 30, 2014 22.86%
June 30, 2014 28.22%
March 31, 2014 26.17%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Invesco Ltd. 17.87%
AllianceBernstein Holding LP --
Franklin Templeton, Inc. 10.09%
Lazard, Inc. 1.53%
T. Rowe Price Group, Inc. 35.62%